Santé log

Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
Santé log

Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.
Santé log

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ...
Santé log

INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts ...
Santé log

Cannabix Secures First Distributor Order for BreathLogix Alcohol Screening Devices in Australia

Breathalyser SSP is a leading distributor of alcohol and drug testing devices for employers and personal use for the Australian market. The company operates regional offices in Perth, Melbourne, and ...
Santé log

iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement

(GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of ...
Santé log

Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary

All intellectual property owned by the Hong Kong subsidiary, including intellectual property owned by Shanghai Sglcell Biotech Co., Ltd., a wholly owned subsidiary of the Hong Kong subsidiary, was ...
Santé log

Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Santé log

SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects

This patent grant in Israel joins previously granted patents for the same technology in Europe, Japan, Australia, and Canada, further strengthening the global intellectual property protection of ...
Santé log

SRx Health Solutions Deploys Initial $10 Million into Several Digital Assets Predominantly Bitcoin and Ethereum

NORTH PALM BEACH, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has deployed an initial $10 million of capital into ...
Santé log

Verano Expands West Virginia Medical Cannabis Dispensary Footprint to Six Statewide Locations with the Opening of Zen Leaf Charleston

Zen Leaf Charleston complements Verano’s five existing West Virginia Zen Leaf locations in Buckhannon, Clarksburg, Morgantown, Westover and Wheeling. According to the West Virginia Department of ...
Santé log

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety . SARASOTA, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ( ...